To scroll text in this page

Global Navigation
Global Navigation end

About Astellas

Start of the main text

2012 News Releases

About RSS

Global News

FDA Advisory Committee Recommends Approval of Mirabegron - Investigational Overactive Bladder Treatment from Astellas (pdf 51KB)

April 6, 2012

Printer-friendly version

Main Text end
Local Navigation
Local Navigation end
Related Links